Optical structural analysis of individual α-synuclein oligomers
Abstract
Small aggregates of misfolded proteins play a key role in neurodegenerative disorders. Such species have proved difficult to study due to the lack of suitable methods capable of resolving these heterogeneous aggregates, which are smaller than the optical diffraction limit. We demonstrate here an all-optical fluorescence microscopy method to characterise the structure of individual protein aggregates based on the fluorescence anisotropy of dyes such as thioflavin-T, and show that this technology is capable of studying oligomers in human biofluids such as cerebrospinal fluid. We first investigated in vitro the structural changes in individual oligomers formed during the aggregation of recombinant α-synuclein. By studying the diffraction-limited aggregates we directly evaluated their structural conversion and correlated this with the potential of aggregates to disrupt lipid bilayers. We finally characterised the structural features of aggregates present in cerebrospinal fluid of Parkinson's disease patients and age-matched healthy controls.
Citation
Varela , J A , Rodrigues , M , De , S , Flagmeier , P , Gandhi , S , Dobson , C M , Klenerman , D & Lee , S F 2018 , ' Optical structural analysis of individual α-synuclein oligomers ' , Angewandte Chemie International Edition , vol. 57 , no. 18 , pp. 4886-4890 . https://doi.org/10.1002/anie.201710779
Publication
Angewandte Chemie International Edition
Status
Peer reviewed
ISSN
1433-7851Type
Journal article
Rights
Copyright © 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Description
This study is supported by the Michael J. Fox Foundation (10200); The Royal Society with a University Research Fellowship (UF120277) (S.F.L.); a Marie‐Curie Individual Fellowship (S.D.); the Boehringer Ingelheim Fonds (P.F.), the Studienstiftung des Deutschen Volkes (P.F.); the UK Biotechnology and Biological Sciences Research Council (C.M.D.); the Wellcome Trust (C.M.D.); the Cambridge Centre for Misfolding Diseases (P.F. and C.M.D.), and the Royal Society and the European Research Council with an ERC Advanced Grant (669237) (D.K.).Collections
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.